Mesenteric artery stenting for chronic mesenteric ischemia

Hadi Rokni Yazdi, Fadi Youness, Sandeep Laroia, Shiliand Sun, Hicham Abada, Melhem Sharafuddin, Jafar Golzarian

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Chronic mesenteric ischemia (CMI), or abdominal angina, is a rare disorder accounting for less than 5% of all intestinal ischemic events, and in more than 90% of instances is caused by atherosclerosis. CMI has the potential to worsen and develop into acute intestinal ischemia with bowel infarction. Therefore, treatment of symptomatic CMI is necessary to prevent acute mesenteric ischemia, which may cause bowel infarction and death. Until recently, open revascularization has been the method of choice for therapy of patients with CMI. However, the rate of major complications is relatively high. As an alternative to open surgical revascularization, PTA was introduced by Furrer et al in 1980. Since then, several studies have presented the results of angioplasty and/or stenting in the treatment of CMI, with a periprocedural mortality rate of 0 to 13%, and complication rate of 0 25%. The technical success rate of PTA is 90 100%.

Original languageEnglish (US)
Pages (from-to)180-184
Number of pages5
JournalVascular Disease Management
Issue number6
StatePublished - Nov 1 2007


Dive into the research topics of 'Mesenteric artery stenting for chronic mesenteric ischemia'. Together they form a unique fingerprint.

Cite this